Literature DB >> 25036229

Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis.

Bon San Koo1, Young Wha Koh, Seokchan Hong, You Jae Kim, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo.   

Abstract

Abstract Objective. The purpose of our study was to determine the number of IgG4-related retroperitoneal fibrosis (RPF) cases that were initially diagnosed as idiopathic RPF and to investigate clinical characteristics of IgG4-related RPF. Methods. We retrospectively reviewed the medical records of 41 RPF patients who were treated at our tertiary care medical center in South Korea between January 2000 and January 2013. We identified cases of 19 patients in which a diagnosis was made based on percutaneous biopsy or surgery and selected these cases for further analysis. Immunostaining for IgG4 and histopathologic examinations were performed for pathology specimens. Results. In the 19 RPF patients, more than 30 IgG4-positive plasma cells per specimen were identified in 9 cases with dense lymphoplasmacytic infiltrates, storiform fibrosis, or obliterative phlebitis (IgG4-related RPF group). The recurrence rate of IgG4-related RPF was significantly higher than that of idiopathic RPF (67% vs. 10%, p = 0.015). Initial and cumulative steroid dosages were not different between the two groups. Conclusions. We found that 47% of the patients initially diagnosed with idiopathic RPF showed IgG4-related RPF evidence according to the pathology and IgG4-related RPF patients showed higher recurrence rate than idiopathic RPF patients. We suggest that maintenance immunosuppressive therapy is required in IgG4-related RPF patients.

Entities:  

Keywords:  Idiopathic retroperitoneal fibrosis; IgG4; IgG4-related retroperitoneal fibrosis

Mesh:

Substances:

Year:  2014        PMID: 25036229     DOI: 10.3109/14397595.2014.931908

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  21 in total

Review 1.  IgG4-related disease: what urologists should know.

Authors:  Daniele Bianchi
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

Review 2. 

Authors:  Nabil Jakhlal; Anouar Elghazoui; Youness Jabbour; Tarik Karmouni; Khalid Elkhader; Abdellatif Koutani; Ahmed Ibenattya
Journal:  Can Urol Assoc J       Date:  2017-01-12       Impact factor: 1.862

Review 3.  Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis.

Authors:  Paride Fenaroli; Federica Maritati; Augusto Vaglio
Journal:  Curr Rheumatol Rep       Date:  2021-02-10       Impact factor: 4.592

Review 4.  Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease.

Authors:  Giovanni Maria Rossi; Rossana Rocco; Eugenia Accorsi Buttini; Chiara Marvisi; Augusto Vaglio
Journal:  Intern Emerg Med       Date:  2017-01-09       Impact factor: 3.397

5.  Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis.

Authors:  L G Pelkmans; T R Hendriksz; P J Westenend; H J Vermeer; E F H van Bommel
Journal:  Clin Rheumatol       Date:  2017-01-19       Impact factor: 2.980

Review 6.  [New (and old) aspects of retroperitoneal fibrosis].

Authors:  A S Brandt; N M Dreger; E Müller; S Kukuk; S Roth
Journal:  Urologe A       Date:  2017-07       Impact factor: 0.639

Review 7.  Retroperitoneal fibrosis - the state-of-the-art.

Authors:  Marta Runowska; Dominik Majewski; Mariusz Puszczewicz
Journal:  Reumatologia       Date:  2016-11-28

8.  Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease.

Authors:  Takanori Sasaki; Mitsuhiro Akiyama; Yuko Kaneko; Takehiko Mori; Hidekata Yasuoka; Katsuya Suzuki; Kunihiro Yamaoka; Shinichiro Okamoto; Tsutomu Takeuchi
Journal:  RMD Open       Date:  2017-07-18

9.  Pathologically Proven Spontaneous Remission of IgG4-related Retroperitoneal Fibrosis.

Authors:  Hideaki Yamakawa; Akimasa Sekine; Yumie Yamanaka; Shinko Sadoyama; Tomohisa Baba; Eri Hagiwara; Koji Okudela; Takashi Ogura
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

10.  Retroperitoneal fibrosis - a report of five cases.

Authors:  Marta Runowska; Dominik Majewski; Mariusz Puszczewicz
Journal:  Reumatologia       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.